IDEXX acquired CoVetAI, an ambient-listening software for veterinary practices

The diagnostics company will integrate CoVet's ambient listening and documentation software into its cloud platform serving 10,000 clinics.

IDEXX acquired CoVetAI, an ambient-listening software for veterinary practices

Photo: CDC · Unsplash

Diagnostics companies are buying their way into the software layer where clinical decisions get made.

The acquisition and what it buys IDEXX

IDEXX Laboratories acquired CoVetAI, a provider of artificial intelligence-based ambient listening and clinical workflow software for veterinary practices. The company did not disclose terms.

CoVetAI automates the capture and organization of patient information from initial consultations through treatment planning, according to IDEXX's release. The software reduces the daily documentation burden on veterinary staff.

IDEXX plans to integrate CoVet into its cloud-based software ecosystem, which currently serves more than 10,000 clinics globally. The release noted that CoVet will continue to support non-IDEXX practice management systems.

The source article described this as the latest in "a string of industry moves as diagnostic companies, distributors, and others aim to win an ecosystem arms race by expanding into software and AI," though it named no other specific transactions.

Our read on the distribution advantage

IDEXX President and CEO Mike Erickson stated that as veterinary practices manage growing complexity and generate more data, "clinical teams need better ways to capture, connect, and use that information." He noted that incorporating CoVet's workflow capabilities will help professionals operate more efficiently and unlock greater value from clinical data.

The 10,000-clinic install base gives IDEXX a distribution channel for CoVetAI's software that changes the adoption curve. A practice already running IDEXX's cloud platform sees the ambient-listening tool as an add-on to an existing relationship, not a new vendor decision.

We write one of these every week for people who run practices and make the software decisions. Subscribe to VeterinaryPracticeNow.

What this changes for the associate DVM and the owner-DVM

For the associate DVM: If your practice runs IDEXX software, you are likely to see ambient AI scribing offered as part of the platform as the integration progresses. Whether it saves you the time you currently spend finishing charts after hours, or whether it produces transcripts you still have to edit line by line, the early pilots will answer. Practices in the IDEXX ecosystem will be the early pilots by default.

The risk: if the integration does not work cleanly, you face another forced software migration inside a system you cannot leave without changing your entire practice management stack. The documentation tool stops being a choice and starts being the thing your employer bought as part of the annual contract.

For the owner-DVM: This acquisition tightens IDEXX's lock-in. Practices already using IDEXX software now have one more feature bundled into the relationship, and one more reason the switching cost to a competitor looks prohibitive. At contract renewal, you will need to determine whether the ambient-listening feature is priced separately or included in the platform, and whether you can decline it without losing access to other integrations you depend on.

The other item for contract review: what data-sharing terms come with the ambient-listening feature. If the software captures your exam room conversations and feeds data back to IDEXX, that is a different deal than a transcription tool that runs locally. The release did not specify, so review that before you turn it on.

The thing to watch

The release said CoVetAI will continue to support non-IDEXX practice management systems. It did not say for how long. That timeline will show whether this was an ecosystem play or a customer-acquisition play, and the difference matters for every practice that is not already locked into IDEXX.

Get the next issue in your inbox. Free, weekly, no fluff.

Unsubscribe anytime.

Source: Today's Veterinary Business

← Back to the Newsdesk